Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT03068013

Managing Cancer and Living Meaningfully (CALM) Adapted to Italian Cancer Care Setting

Led by Università degli Studi di Ferrara · Updated on 2024-07-03

171

Participants Needed

1

Research Sites

320 weeks

Total Duration

On this page

Sponsors

U

Università degli Studi di Ferrara

Lead Sponsor

P

Princess Margaret Hospital, Canada

Collaborating Sponsor

AI-Summary

What this Trial Is About

Background: Patients with advanced cancer suffer from a variety of psycho-social symptoms that impair quality of life and may benefit from psychotherapeutic treatment. We describe here the methodology of a randomized controlled trial to test the effectiveness of a novel and brief semi-structured psychotherapeutic intervention, called Managing Cancer and Living Meaningfully (CALM), originally developed in Canada and now cross-culturally tested in Italy. Methods/Design: The study is a single-blinded randomized controlled trial with 2 conditions: CALM intervention versus nonspecific supportive intervention (SPI) and assessments at baseline, 3 and 6 months. The coordinating site is the Program on Psycho-Oncology and Psychiatry in Palliative Care, University of Ferrara and Integrated Department of Mental Health, S. Anna University Hospital, in Ferrara, Italy. Another centre from northern and southern Italy will collaborate. Eligibility criteria include: ≥ 18 years of age; Italian fluency; no cognitive impairment; and diagnosis of advanced cancer. The intervention consists of 12 sessions , following the CALM manual and allowing for flexibility to meet individual patients' needs. It is delivered over a 6-month period and provides reflective space for patients (and their primary caregivers) to address 4 main domains: symptom management and communication with health care providers; changes in self and relations with close others; sense of meaning and purpose; and the future and mortality. The primary outcome is depression and the primary endpoint is at 6 months. Secondary outcomes include demoralization, generalized anxiety, death anxiety, spiritual well-being, quality of life, attachment security, posttraumatic growth, communication with partners, and satisfaction with clinical interactions. Discussion: This trial is being conducted to determine the effectiveness of CALM in an Italian cancer setting. The intervention has potential cross-national relevance and, if shown to be effective, has the potential to be disseminated as a new approach in oncology to relieve distress and promote psychological well-being in patients with advanced cancer.

CONDITIONS

Official Title

Managing Cancer and Living Meaningfully (CALM) Adapted to Italian Cancer Care Setting

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or more
  • Fluency in Italian language
  • No cognitive impairment
  • Diagnosis of advanced cancer (specific stages of lung, pancreatic, ovarian, gynecological, breast, genitourinary, gastrointestinal, melanoma, sarcoma, or endocrine cancers) with expected survival of 12-18 months
  • Score of 10 or higher on the Patient Health Questionnaire or 20 or higher on the Death and Dying Distress Scale
Not Eligible

You will not qualify if you...

  • Communication difficulties that hinder psychotherapy
  • Inability to commit to the required 12 therapy sessions
  • Currently receiving psychotherapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Università di Ferrara

Ferrara, Emilia-Romagna, Italy, 44100

Actively Recruiting

Loading map...

Research Team

L

Luigi Grassi, M.D.

CONTACT

R

Rosangela Caruso, M.D., PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here